Literature DB >> 16135402

Potential irritation of lysine derivative surfactants by hemolysis and HaCaT cell viability.

L Sanchez1, M Mitjans, M R Infante, M P Vinardell.   

Abstract

Surfactants represent one of the most common constituents in topical pharmaceutical and cosmetic applications or cleansers. Since adverse skin and ocular reactions can be caused by them, it is important to evaluate damaging effects. Amino acid-based surfactants deserve particular attention because of their low toxicity and environmental friendly properties. New lysine derivative surfactants associated with heavy and light counterions were tested. The ocular irritancy was assessed by hemolysis, and photohemolysis was employed to evaluate their phototoxicity. Cytotoxicity on HaCaT cells was determined by neutral red uptake and MTT assay to predict skin irritation. All lysine derivative surfactants were less hemolytic and thus less eye-irritating than the commercial surfactants used as model irritants. No phototoxic effects were found. All surfactants presented cytotoxic effects as demonstrated by decrease of neutral red uptake and reduction of MTT salt, with clear concentration-effect profiles. However, the rates of cytotoxicity on HaCaT for the new surfactants suggested that they were less cytotoxic and then, less skin-irritating than the reference ones; surfactants with heavy counterions were the less cytotoxic. The anionic surfactants investigated in the present work may constitute a promising class of surfactants given their low irritancy potential for pharmaceutical and cosmetic preparations.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16135402     DOI: 10.1016/j.toxlet.2005.07.015

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  8 in total

Review 1.  Exploration of novel drug delivery systems in topical management of osteoarthritis.

Authors:  Pratiksha Patil; Shweta Nene; Saurabh Shah; Shashi Bala Singh; Saurabh Srivastava
Journal:  Drug Deliv Transl Res       Date:  2022-08-28       Impact factor: 5.671

2.  Exposure to the proton scavenger glycine under alkaline conditions induces Escherichia coli viability loss.

Authors:  Donna Vanhauteghem; Geert Paul Jules Janssens; Angelo Lauwaerts; Stanislas Sys; Filip Boyen; Eric Cox; Evelyne Meyer
Journal:  PLoS One       Date:  2013-03-27       Impact factor: 3.240

3.  Dicationic alkylammonium bromide gemini surfactants. Membrane perturbation and skin irritation.

Authors:  João A S Almeida; Henrique Faneca; Rui A Carvalho; Eduardo F Marques; Alberto A C C Pais
Journal:  PLoS One       Date:  2011-11-10       Impact factor: 3.240

4.  Selected Biomarkers Revealed Potential Skin Toxicity Caused by Certain Copper Compounds.

Authors:  Hairui Li; Pei Zhen Toh; Jia Yao Tan; Melvin T Zin; Chi-Ying Lee; Bo Li; Melvina Leolukman; Hongqian Bao; Lifeng Kang
Journal:  Sci Rep       Date:  2016-11-28       Impact factor: 4.379

Review 5.  Alternatives to In Vivo Draize Rabbit Eye and Skin Irritation Tests with a Focus on 3D Reconstructed Human Cornea-Like Epithelium and Epidermis Models.

Authors:  Miri Lee; Jee-Hyun Hwang; Kyung-Min Lim
Journal:  Toxicol Res       Date:  2017-07-15

6.  Lipophilic Arginine Esters: The Gateway to Preservatives without Side Effects.

Authors:  Iram Shahzadi; Aamir Jalil; Mulazim Hussain Asim; Andrea Hupfauf; Ronald Gust; Philipp Alexander Nelles; Ludwig Knabl; Andreas Bernkop-Schnürch
Journal:  Mol Pharm       Date:  2020-07-09       Impact factor: 4.939

7.  1,4-dihydroxy-2-naphthoic Acid Induces Apoptosis in Human Keratinocyte: Potential Application for Psoriasis Treatment.

Authors:  Chong-Fai Mok; Chuan-Ming Xie; Kathy Wai-Yan Sham; Zhi-Xiu Lin; Christopher Hon-Ki Cheng
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-11       Impact factor: 2.629

8.  Eye Irritation Potential of Microglycine and Microglycine-Containing Ointments: An in vitro Study on Reconstructed Human Corneal Epithelium.

Authors:  Laura Ceriotti; Silvia Balzaretti; Salvatore Barone; Marisa Meloni
Journal:  Clin Ophthalmol       Date:  2020-01-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.